Impel Pharmaceuticals Inc

0.00 (+0.27%)
5:55:13 PM EDT: $0.59 +0.04 (+6.71%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)13.10M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8 Million
Adjusted EPS-$0.36
See more estimates
10-Day MA$0.56
50-Day MA$0.89
200-Day MA$1.79
See more pivots

Impel Pharmaceuticals Inc Stock, NASDAQ:IMPL

201 Elliott Avenue West, Suite 260, Seattle, Washington 98119
United States of America
Phone: +1.206.568.1466
Number of Employees: 160


Impel Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. It engages in the development and commercialization of transformative therapies for patients suffering from diseases with high unmet medical needs with an initial focus on diseases of the central nervous system. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.